COVIDRIVE welcomes three new vaccine companies to the consortium
Moderna, Novavax and Valneva have joined COVIDRIVE, a public-private partnership [...]
About Roberto Bonaiuti
This author has not yet filled in any details.So far Roberto Bonaiuti has created 78 blog entries.
DRIVE Public-Private Brainstorming sessions 2022
DRIVE WP7 and EFPIA partners will meet up again for [...]
DRIVE celebrates its 4th Annual Meeting
More than 100 influenza and COVID-19 experts came together for [...]
DRIVE Annual Forum 2021- Save the date: 30th November
With the end of the project right around the corner, [...]
DRIVE results for the 2020/21 season
DRIVE’s yearly results report, which has been submitted to IMI [...]
Launch of an ambitious cross-pharma study by the public-private partnership ‘COVIDRIVE’: a multi-country European study to continuously monitor COVID-19 vaccine effectiveness against severe disease
17/09/2021 - COVIDRIVE, a long-term, multi-country, hospital-based study investigating the [...]
DRIVE patient groups involvement initiative
The DRIVE team is seeking feedback and recommendations from patient [...]
New Public-private Partnership COVIDRIVE To Assess brand-specific COVID-19 Vaccine Effectiveness In Europe
Study findings will help to inform decision-making by public health [...]
What factors drive choices between types and brands of influenza vaccines in general practice in Europe?
DRIVE walks you through some of them on its latest [...]
DRIVE celebrates its first Inter-work package workshop to strengthen the project’s internal communications
After nearly 4 years of intense work and study in [...]